Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Inv. presentation
Quarterly results
Class action filed
Director departure
Appointed director
CC transcript

INSPIRE PHARMACEUTICALS INC (ISPH) Create: Alert

All | News | Filings
Date FiledTypeDescription
04/22/2011 BW Inspire Postpones Annual Meeting of Stockholders Due to Recently Announced Tender Offer
04/08/2011 BW The Law Offices of Vincent Wong Announce an Investigation into Possible Breaches of Fiduciary Duty by the Board of Inspire Pharmaceuticals, Inc. in Connection with the Sale of the Company to Merck – ISPH
04/07/2011 BW Faruqi & Faruqi, LLP Announces Shareholder Investigation Related to the Acquisition of Inspire Pharmaceuticals, Inc. - ISPH
04/07/2011 BW The Law Firm of Weiss & Lurie Investigates the Acquisition of Inspire Pharmaceuticals, Inc.
04/06/2011 BW Law Office of Brodsky & Smith, LLC Announces Investigation of Inspire Pharmaceuticals, Inc.
04/06/2011 BW The Law Office of Abe Shainberg Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Inspire Pharmaceuticals, Inc. in Connection with the Sale of the Company to Merck – ISPH
04/06/2011 BW Briscoe Law Firm and Powers Taylor LLP Investigate Inspire Pharmaceuticals, Inc. for Shareholders Concerning Merck Acquisition
04/05/2011 BW The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Inspire Pharmaceuticals, Inc. in Connection with the Sale of the Company to Merck – ISPH
02/24/2011 BW Inspire Announces Webcast of Presentation at Citi Global Healthcare Conference
02/17/2011 BW Inspire Reports Fourth Quarter and Full Year 2010 Financial Results
02/17/2011 BW Inspire Announces Corporate Restructuring and Strategic Focus on Eye Care Business
02/14/2011 BW Inspire Announces Date for Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2010 Financial Results and Provide Corporate Update
12/13/2010 BW Inspire Announces Launch of DIQUASTM by Santen in Japan
11/04/2010 BW Inspire Reports Third Quarter 2010 Financial Results
10/21/2010 BW Data Presentations at North American Cystic Fibrosis Conference Highlight Denufosol's Novel Mechanism of Action
09/17/2010 BW Data to Be Presented at ERS Conference Highlights Potential for Denufosol to Benefit Cystic Fibrosis Patients on Minimal Pharmacotherapy
09/08/2010 BW Inspire Announces Webcast of Presentation at Stifel Nicolaus Healthcare Conference
08/25/2010 BW Inspire Announces Amendment to Ophthalmic Collaboration
08/13/2010 BW Inspire Names Dr. Charles Johnson as Executive Vice President of Research and Development and Chief Medical Officer
07/22/2010 BW Inspire Announces Date for Conference Call and Webcast to Discuss Second Quarter 2010 Financial Results
07/01/2010 BW Inspire Announces Management Structure Changes
06/03/2010 BW Inspire Announces Webcasts of Presentations at Needham Healthcare Conference and Jefferies Life Sciences Conference
05/03/2010 BW Inspire Reports First Quarter 2010 Financial Results
04/27/2010 BW Inspire Announces Webcast of Presentation at Deutsche Bank Health Care Conference
04/19/2010 BW Inspire Announces Date for Conference Call and Webcast to Discuss First Quarter 2010 Financial Results
04/16/2010 BW Santen and Inspire Announce Approval of DIQUASTM for Dry Eye Treatment in Japan
04/13/2010 BW Inspire Appoints Andrew Koven as Executive Vice President and Chief Administrative and Legal Officer
03/15/2010 BW Inspire Announces Results From AZASITE® Phase 2 Blepharitis Trials and Plans to Continue Clinical Development in Anterior and Posterior Blepharitis
03/04/2010 BW Inspire Reports Fourth Quarter and Full Year 2009 Financial Results
03/02/2010 BW Inspire Announces Webcast of Presentation at Cowen Health Care Conference
03/01/2010 BW Inspire Elects George Abercrombie to Board of Directors
02/26/2010 BW Inspire Announces Date for Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2009 Financial Results
02/23/2010 BW Inspire Announces Grants Under NASDAQ Marketplace Rule 5635
02/19/2010 BW Inspire Names Adrian Adams as President and Chief Executive Officer

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy